Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05235113 · ClinicalTrials.gov registry record · NA

Remote Game-based Exercise Program for Cognitive and Motor Function Improvement

A NA study of Mild Cognitive Impairment and Dementia, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
84
Enrollment target
2
Study locations

NCT05235113: Active NA study of Mild Cognitive Impairment and Dementia, sponsored by University of California, Los Angeles.

NCT05235113 is a NA study of Mild Cognitive Impairment and Dementia that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 84 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05235113, a NA study of Mild Cognitive Impairment and Dementia, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
84 participants
Enrollment target
2
Study locations

Study Summary

As our population ages, more older adults face motor-cognitive declines, increasing their risk of falls and fear of falling. Exercise is an effective way to maintain cognitive function, as supported by recent studies. However, those with poor motor and cognitive abilities often struggle to visit rehabilitation centers, leading to high dropout rates and low adherence to unsupervised programs. A remote exercise program tailored for individuals with cognitive impairments is urgently needed to preserve cognitive function, promote independent living, and reduce related costs. Researchers aim to develop an in-home system for adults with mild cognitive issues or dementia, designed to improve balance and cognition while being remotely supervised through telemedicine.

Primary Outcome

Change in balance from baseline to 12 weeks will be measured. Balance will be assessed by measuring center of mass sway. The investigator will use a validated wearable platform (BalanSen) to measure body sway.

Conditions Studied

Mild Cognitive Impairment Dementia Cognitive Impairment Memory Loss

Interventions

  • DEVICE Tele-Exergame Platform
  • DEVICE No Tele-Exergame Platform

Study Locations (2)

California

  • UCLA - Los Angeles

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2023-11-03
Est. Completion 2026-06-30
Phase NA
University of California, Los Angeles

897 total trials

What the registry record for NCT05235113 still lists

NCT05235113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Tele-Exergame Platform is the first listed.

NCT05235113 reports a single indexed study location in California, Texas.

Frequently Asked Questions

What is clinical trial NCT05235113 about?

NCT05235113 is a clinical study titled "Remote Game-based Exercise Program for Cognitive and Motor Function Improvement". As our population ages, more older adults face motor-cognitive declines, increasing their risk of falls and fear of falling. Exercise is an effective way to maintain cognitive function, as supported by recent studies. However, those with poor motor and cognitive abilities often struggle to visit reh...

What is the current status of trial NCT05235113?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2023-11-03. Estimated completion is 2026-06-30.

What conditions does trial NCT05235113 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia, Cognitive Impairment, Memory Loss.

What interventions are being tested in trial NCT05235113?

The interventions under investigation include: Tele-Exergame Platform (DEVICE), No Tele-Exergame Platform (DEVICE).

Who is sponsoring clinical trial NCT05235113?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05235113 being conducted?

This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05235113's enrollment target sits among peer trials

84 100th of 205 higher than 106 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05235113, the US trial registry maintained by the National Library of Medicine. NCT05235113 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.